An indirect method for obtaining a reliable measure of the rate of glucose transport into adipocytes is described. Evidence is presented that altered levels of 3':5'-cyclic AMP can influence the transport of glucose into adipocytes. When cyclic AMP levels were lowered with antilipolytic agents (insulin, nicotinic acid, or clofibrate), rates of glucose transport were increased. In contrast, when adipose tissue levels of cyclic AMP were elevated by lipolytic hormones or theophylline, glucose transport was inhibited. Insulin no longer increased glucose transport when cyclic AMP levels were elevated by lipolytic agents. Agents that can raise cyclic AMP but inhibit lipolysis (procaine, amitryptyline, and phenylethylbiguanide) reduced the rate of glucose transport. Other data are presented that are consistent with the conclusion that cyclic AMP inhibits glucose transport into adipocytes.
The relatively small intracellular water volume in adipose tissue makes it technically difficult to measure rates of glucose transport into adipocytes (1) . This rate is usually determined by measuring the volume of distribution of added glucose or derivatives in cells rapidly separated from the incubation medium or by measuring countertransport from prelabeled adipocytes (1) (2) (3) (4) (5) (6) (7) (8) (9) . However, these methods suffer from the disadvantage that incubation is required at reduced temperature or for very short time intervals. The magnitude of the response of the glucose transport system in adipocytes to insulin as observable by previously used methods is small compared to the observed increases in rates of glucose metabolism. Consequently, a considerable portion of information relating to glucose transport in adipose tissue has been inferred from indirect techniques in which glucose utilization has been measured (10) (11) (12) . Even though these indirect techniques do not clearly dissociate effects on glucose transport from effects on subsequent glucose metabolism, it is generally accepted that insulin stimulates glucose transport in adipose tissue (for review, see ref. 13 ).
Addition of insulin to adipose tissue results in a fall in levels of 3':5'-cyclic AMP (cAMP) (for review, see refs. 13 and 14) . Evidence is lacking, however, that the insulin-induced decrease in cAMP is directly associated with increased glucose transport. The apparent absence of an influence of cAMP on glucose transport is incompatible with the possibility of a unitary concept that would link the major metabolic effects of insulin to its actions on intracellular cAMP levels (15) .
In this report, we first describe a method to determine the rate of glucose transport in adipocytes. This technique offers several advantages over those previously described in that incubation is permitted at normal temperatures for longer periods. Using this method, we then report observations demonstrating an inverse correlation between adipocyte cAMP levels and the rate of glucose transport. On the basis of these data, we discuss the hypothesis that the major actions of insulin in adipose tissue may result from a reduction of intracellular cAMP concentrations.
METHODS
Rats. Male Wistar rats (100-150 g, Canadian Breeding Laboratories, LaPraire, Quebec) were fed ad libitum on a Purina Lab Chow diet, and were killed by decapitation at approximately 10:00 a.m. In each experiment the animals were of similar age and weight. Where indicated, rats were starved for 48 hr and refed on high carbohydrate diet for 36 hr before they were killed. In all cases, the epidymal fat pads were rapidly removed and placed in a buffered solution at room temperature as described (16 5) , in a volume of 2.5 ml per fat pad as described (16) . The concentrations of the various additions are given in the tables or text. Isolated adipocytes were prepared as described by Rodbell (17) , modified such that the glucose concentration was 1.67 mM. The cells were washed twice in glucose-free medium.
Assay of [1-14C] Glucose Conversion to '4C02. Adipocytes (15-20 mg of lipid) were incubated at 370 for 45 min in a bicarbonate-buffered medium containing 0.25 mM glucose. Sodium fluoride (10 mM) was added to inhibit glycolysis. PMS (20 ,uM) was added to increase glucose oxidation in the pentose phosphate pathway. This concentration of PMS was chosen because it produced near maximal rates of A4C02 production.
PMS concentrations exceeding 100,uM resulted in an inhibition of 14CO2 production. Incubations were terminated by the addition of 0.8 ml of 5% HC104, after which the 14CO2 was trapped on filter paper impregnated with hyamine hydroxide.
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Abbreviations: cAMP, adenosine 3':5'-cyclic monophosphate; PMS, phenazinemethosulfate. Extraction and Analysis of Fat Pads. At the end of the incubation, pads were blotted lightly and frozen in liquid nitrogen. A portion was extracted in 25 ml of chloroform-methanol (2:1, vol/vol) and assayed for 3H in fatty acids. Another portion was extracted in 0.5 M perchloric acid and ether for measurement of metabolic intermediates (16) . In experiments where D-[ U-'4C]xylose distribution volumes were measured, paired fat pads were treated as described by Goodman (2) .
Adipocyte cAMP was assayed using the kit TRK 431 supplied by Amersham/Searle (18) . Glycogen was hydrolyzed to glucose before assay (19) .
Ice-cold perchloric acid extracts of isolated fat cells (100 mg of lipid) were neutralized with KHCO3 and centrifuged at 2,000 X g for 5 min in a bench centrifuge. The clear infranatant solution was transferred to a column of Dowex 50 X 8-100 cation exchange resin in the H-form (column, 12 X 1.5 cm) and extensively washed with distilled water (1-1.5 liters). The column was finally washed with 15 ml of 0.01-M HC1 and the [1-14C] glucose-derived metabolites were eluted with 120 ml of 0.04 M HCI. Aliquots of the eluate (4 ml) were then mixed with 8 ml of aquasol for determination of the 14C activity. Radioactive Assay. 14C and 3H radioactivity were assayed in a Beckman model LS 230 liquid-scintillation system, using toluene scintillator containing 2,5-diphenyloxazole and 1,4-bis[2(5-phenyloxasolyl)]benzene (20) . Quenching corrections were applied from the channels-ratio method by using an external standard.
RESULTS AND DISCUSSION Development of a Method to Measure Glucose Transport. The rationale for the method to be presented is based on information summarized in Fig. 1 . Conversion of glucose-6-phosphate to pyruvate is blocked by fluoride (21) , and the rate of the pentose phosphate pathway is augmented by the addition of PMS, an agent which permits rapid oxidation of NADPH to NADP. In cells treated in this manner, the regulation of the pentose phosphate pathway by the NADP/NADPH ratio is bypassed (22) (23) (24) (25) . In such a system, the conversion of [ Insulin, where present, was at a concentration of 500 microunits/ml.
After the designated times, 0.8 ml of 5% HCl04 was added to the incubation medium and hyamine was used to trap the "4C02. This maximum rate of glucose transport was similar when methylene blue replaced PMS (results not shown).
In the absence of PMS, the adipocyte glucose-6-phosphate concentration is at least an order of magnitude greater than the Km for glucose-6-phosphate dehydrogenase (10,M). The maximum velocity for this step at 370 is 3100 nmol/min per g of lipid and the maximum velocity for 6-phosphogluconate dehydrogenase at 370 is 1500 nmol/min per g of lipid (26) . The maximum velocity for hexokinase at 300 is 600 nmol/min per g of lipid (27) . These values exceed the maximum reported rates for glucose transport in this paper by at least 6-fold. Therefore, it is likely that [1-14C] (28) . These data confirm that the volume of distribution of D-[U-'4C]xylose in fat tissue can be used only with difficulty to evaluate possible influences of various agents on sugar transport. Qualitatively, the changes observed in insulin-or procaine-treated fat pads (Table 2) are consistent with those elicited in adipocytes ( Fig. 2 and Table 1 ). Results obtained with both methods indicate that insulin increases sugar transport while procaine inhibits it. The effects are more clearly evident and more readily amenable to further exploration when rates of [1-_4C]glucose conversion to 14CO2 are measured under conditions described in the legend of Fig. 2 , using the approach shown in Fig. 1 . Based on the assumption that measurements of these rates provide an index of the rates of glucose transport (29) , also was a potent inhibitor of glucose transport (Table 4 ). All of the agents thus far reported that inhibited glucose transport also increased lipolysis, as measured by the rate of release of glycerol (Tables 3 and 4 ).
Another group of compounds was tested that has been reported to inhibit lipolysis, even though they cause cAMP levels to be elevated. These compounds include procaine (30, 31) , amitriptyline (32) , and phenylethylbiguanide (33, 34 (Tables 3 and 4) . Therefore, the data are consistent with an inhibition of glucose transport by agents that elevate cAMP levels and an augmentation of glucose transport by agents that lower cAMP levels. Rates of lipolysis are not inversely correlated to the rates of glucose transport, however, indicating different regulatory sites for these two processes.
It is of interest that isoproterenol, a ,B-adrenergic stimulator, was a potent inhibitor of apparent glucose transport, whereas propranolol, a fi-adrenergic blocking agent, was without influence when added alone (Table 4 ). The effects of isoproterenol, however, were partially blocked when propranolol was present. The degree of blockade of the isoproterenol effect on glucose transport was parallel with that elicited on lipolysis (Table 4) .
The ability of insulin to increase the apparent rate of glucose transport is no longer observed when high doses of lipolytic agents are also present. The level of cAMP was not decreased to control levels under these conditions (Table 3 ). These data add further support for a role of cAMP in the control of glucose transport.
Comparison of Extracellular Glucose and Tissue Glycogen as Substrates for Fatty Acid Synthesis. Procaine, which decreased [1-'4C]glucose conversion to '4C02 (Tables 1 and 4) , inhibited the conversion of externally added glucose to glyceride fatty acids by about 50% in fat pads obtained from normal fed rats and incubated in the absence of insulin. Under these conditions, the glucose-6-phosphate concentration was decreased approximately 10-fold in the presence of procaine (from 11.7 + 0.9 to 1.2 + 0.3 nmol/g of tissue, n = 8, P < 0.01). In contrast, the synthesis of glyceride fatty acids from endogenous carbohydrate stores was unaffected by procaine (Table 5 ).
Starved and refed rats were chosen for this experiment because of their high glycogen content (35) . Thus, procaine inhibited Table 3 . Effect of agents on apparent rates of glucose transport as measured by effect on rates of conversion of [1--4C] glucose to '4C2., glycerol release, and intracellular levels of cAMP Epididymal fat pads were obtained from rats fed ad libitum or starved and refed as described in Methods. The fat pads were incubated for 30 min in the absence of substrates and then distributed into paired flasks. Each flask contained 2.5 ml of bicarbonate buffer per fat pad and 200 ,Ci of 3H20 per ml. Procaine was added at a final concentration of 4 mM, and glucose was 10 mM. The flasks were gassed with C02/02 5:95 and incubated for 60 min. Results are reported as mean ±SEM for the number of paired observations indicated in parentheses. * P < 0.01 for effect of procaine.
have observed that glucose transport is inhibited when adipocytes are incubated with ATP and that phosphorylation was probably required. In a recent report, Avruch et al. (37) noted that membrane proteins were phosphorylated after incubation of adipocytes with lipolytic hormones. It is possible to speculate that the cAMP-induced inhibition of glucose transport is mediated by cAMP-catalyzed phosphorylation of membrane proteins (presumably the glucose transporter) by ATP.
Although the results reported are consistent with an effect of cAMP on glucose transport, it obviously does not follow that the control of glucose transport by insulin is mediated solely by regulation of cAMP concentration or even cAMP partition. In previous studies with fat cell "ghosts", lipolytic hormones or theophylline inhibited glucose utilization, possibly by elevating cAMP levels, but these agents did not inhibit insulin-stimulated glucose transport (4). These results differ from those reported in this paper. In addition, lipolytic hormones have been shown to increase glucose utilization in adipose tissue at times when cAMP levels are high. These data indicate that glucose transport can be increased in response to other stimuli even when cAMP levels are elevated (38) . Intracellular partition of cAMP is also likely, since some agents increase cAMP levels without increasing lipolysis (30) (31) (32) (33) (34) (i.e., procaine, amitriptyline, or phenylethylbiguanide), even though these same agents do inhibit glucose transport (Table 4) .
